IDWeek and HIV Glasgow 2024
CCO Independent Conference Coverage of IDWeek and Glasgow 2024  

Released: December 18, 2024

Expiration: December 17, 2025

Joseph J. Eron, Jr.
Joseph J. Eron, Jr., MD
Jean-Michel Molina
Jean-Michel Molina, MD, PhD

Activity

Progress
1
Course Completed

In this episode, Jean-Michel Molina, MD, PhD, and Joseph J. Eron, Jr., MD, discuss results from key clinical trials on HIV prevention and treatment as well as sexually transmitted infection (STI) prevention presented at IDWeek and Glasgow 2024, including:

  • PURPOSE 1 and 2 comparing lenacapavir injection vs oral TDF/FTC
  • TRIO Health Cohort and OPERA examining long-acting cabotegravir as PrEP
  • DOLCE comparing DTG/3TC as first-line therapy in treatment-naive patients with HIV
  • PRIDOX evaluating the use of DoxyPEP on STI incidence in men who have sex with men on PrEP